Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia

NCT07490327 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia

Interventions

DRUG: AD-303A
DRUG: AD-3031

Sponsor

Moogene Medi Co., Ltd

Collaborators

[object Object]